U.S. flag

An official website of the United States government

NM_000151.4(G6PC1):c.969C>A (p.Tyr323Ter) AND not provided

Germline classification:
Pathogenic (3 submissions)
Last evaluated:
Sep 20, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000726277.6

Allele description [Variation Report for NM_000151.4(G6PC1):c.969C>A (p.Tyr323Ter)]

NM_000151.4(G6PC1):c.969C>A (p.Tyr323Ter)

Gene:
G6PC1:glucose-6-phosphatase catalytic subunit 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q21.31
Genomic location:
Preferred name:
NM_000151.4(G6PC1):c.969C>A (p.Tyr323Ter)
Other names:
p.Tyr323*
HGVS:
  • NC_000017.11:g.42911321C>A
  • NG_011808.1:g.15524C>A
  • NM_000151.4:c.969C>AMANE SELECT
  • NM_001270397.2:c.*361C>A
  • NP_000142.2:p.Tyr323Ter
  • LRG_147:g.15524C>A
  • NC_000017.10:g.41063338C>A
  • NM_000151.2:c.969C>A
  • NM_000151.3:c.969C>A
Protein change:
Y323*
Links:
dbSNP: rs780226142
NCBI 1000 Genomes Browser:
rs780226142
Molecular consequence:
  • NM_001270397.2:c.*361C>A - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_000151.4:c.969C>A - nonsense - [Sequence Ontology: SO:0001587]
Observations:
2

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000343386Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions 2015)
Pathogenic
(Jun 29, 2016)
germlineclinical testing

Citation Link,

SCV004228180Mayo Clinic Laboratories, Mayo Clinic
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 27, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV005327149GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Sep 20, 2024)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknown2not providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.

Calderaro J, Labrune P, Morcrette G, Rebouissou S, Franco D, Prévot S, Quaglia A, Bedossa P, Libbrecht L, Terracciano L, Smit GP, Bioulac-Sage P, Zucman-Rossi J.

J Hepatol. 2013 Feb;58(2):350-7. doi: 10.1016/j.jhep.2012.09.030. Epub 2012 Oct 6.

PubMed [citation]
PMID:
23046672

Glycogen storage diseases: Twenty-seven new variants in a cohort of 125 patients.

Sperb-Ludwig F, Pinheiro FC, Bettio Soares M, Nalin T, Ribeiro EM, Steiner CE, Ribeiro Valadares E, Porta G, Fishinger Moura de Souza C, Schwartz IVD.

Mol Genet Genomic Med. 2019 Nov;7(11):e877. doi: 10.1002/mgg3.877. Epub 2019 Sep 11.

PubMed [citation]
PMID:
31508908
PMCID:
PMC6825860
See all PubMed Citations (4)

Details of each submission

From Eurofins Ntd Llc (ga), SCV000343386.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

From Mayo Clinic Laboratories, Mayo Clinic, SCV004228180.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (4)

Description

PM2, PM3_supporting, PS3, PVS1_strong

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

From GeneDx, SCV005327149.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Reported in a patient in the published literature with glycogen storage disease type 1 (PMID: 23046672); Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation, as the last 35 amino acids are lost, and other loss-of-function variants have been reported downstream in HGMD; Published functional studies demonstrate a damaging effect on protein expression (PMID: 34258141); This variant is associated with the following publications: (PMID: 10070617, 11949931, 31508908, 8182131, 7573034, 8733042, 28397058, 23046672, 34258141)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024